Found 90 with Last Name = 'cocklin' and Initial = 's' 
Affinity DataKi: 2.80nMAssay Description:Binding affinity to ACE2 (unknown origin) at 10 uM assessed as inhibition constantMore data for this Ligand-Target Pair
Affinity DataKi: 4.59E+5nMAssay Description:Binding affinity to ACE2 (unknown origin) at 10 uM assessed as inhibition constantMore data for this Ligand-Target Pair
Affinity DataIC50: 0nMAssay Description:Inhibition of human recombinant Cathepsin L assessed as Kinact using Z-FR-AMC as substrate incubated for 30 mins by fluorometric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.680nMAssay Description:Inhibition of human recombinant Cathepsin L assessed as Kinact using Z-FR-AMC as substrate incubated for 30 mins by fluorometric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant ACE2 at 50 uM using (7Mca-Y-V-A- D -A-P- K(Knp) as a flurogenic substrate measured after 10 mins by fluorescence base...More data for this Ligand-Target Pair
Affinity DataIC50: 1.90nMAssay Description:Inhibition of SARS-CoV S binding to human recombinant ACE2 expressed in Escherichia coli BL21(DE3) incubated for 2 hrs by ELISA methodMore data for this Ligand-Target Pair
Affinity DataIC50: 2.5nMAssay Description:Inhibition of human recombinant Cathepsin L assessed as Kinact using Z-FR-AMC as substrate incubated for 30 mins by fluorometric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.30nMAssay Description:Inhibition of SARS-CoV S binding to human recombinant ACE2 expressed in Escherichia coli BL21(DE3) incubated for 2 hrs by ELISA methodMore data for this Ligand-Target Pair
Affinity DataIC50: 6.90nMAssay Description:Inhibition of human recombinant Cathepsin L assessed as Kinact using Z-FR-AMC as substrate incubated for 30 mins by fluorometric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 7nMAssay Description:Inhibition of SARS-CoV S binding to human recombinant ACE2 expressed in Escherichia coli BL21(DE3) incubated for 2 hrs by ELISA methodMore data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of human ACE2 (unknown origin) at 0.5 uMMore data for this Ligand-Target Pair
Affinity DataIC50: 56nMAssay Description:Inhibition of human recombinant Cathepsin L assessed as Kinact using Z-FR-AMC as substrate incubated for 30 mins by fluorometric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Binding affinity of SARS-COV2 S-RBD by BLI assayMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of human recombinant ACE2 at 50 uM using (7Mca-Y-V-A- D -A-P- K(Knp) as a flurogenic substrate measured after 10 mins by fluorescence base...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Inhibition of human recombinant ACE2 at 50 uM using (7Mca-Y-V-A- D -A-P- K(Knp) as a flurogenic substrate measured after 10 mins by fluorescence base...More data for this Ligand-Target Pair
Affinity DataIC50: 220nMAssay Description:Displacement of CPSF6 peptide from HIV1 capsid protein by surface plasmon resonance-based competition assayMore data for this Ligand-Target Pair
Affinity DataIC50: 440nMAssay Description:Inhibition of human recombinant ACE2 at 50 uM using (7Mca-Y-V-A- D -A-P- K(Knp) as a flurogenic substrate measured after 10 mins by fluorescence base...More data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Inhibition of SARS-COV2 spike protein mediated infection of human ACE2 expressing cells at 50 uM by SPR analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 700nMAssay Description:Inhibition of SARS-COV2 S-RBD binding to human ACE2 expressed in HEK293T cells by NanoLuc luciferase assayMore data for this Ligand-Target Pair
Affinity DataIC50: 720nMAssay Description:Inhibition of human recombinant ACE2 at 50 uM using (7Mca-Y-V-A- D -A-P- K(Knp) as a flurogenic substrate measured after 10 mins by fluorescence base...More data for this Ligand-Target Pair
Affinity DataIC50: 1.13E+3nMAssay Description:Inhibition of human recombinant ACE2 at 50 uM using (7Mca-Y-V-A- D -A-P- K(Knp) as a flurogenic substrate measured after 10 mins by fluorescence base...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human recombinant ACE2More data for this Ligand-Target Pair
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of ABL2 (unknown origin) by Nano-syn mobility shift assayMore data for this Ligand-Target Pair
3D Structure (crystal)
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of SARS-COV2 S-RBD binding to human ACE2 expressed in HEK293T cells by NanoLuc luciferase assayMore data for this Ligand-Target Pair
Affinity DataIC50: 3.47E+3nMAssay Description:Displacement of NUP153 peptide from HIV1 capsid protein by surface plasmon resonance-based competition assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.11E+3nMAssay Description:Inhibition of SARS-COV2 spike protein mediated infection of human ACE2 expressing cells at 50 uM by SPR analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 4.50E+3nMAssay Description:Inhibition of SARS-COV2 spike protein mediated infection of human ACE2 expressing cells at 50 uM by SPR analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 5.33E+3nMAssay Description:Inhibition of human recombinant Cathepsin L assessed as Kinact using Z-FR-AMC as substrate incubated for 30 mins by fluorometric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of human wild type full length ACE2 peptide assessed as inhibitionMore data for this Ligand-Target Pair
Affinity DataIC50: 8.93E+3nMAssay Description:Displacement of NUP153 peptide from HIV1 capsid protein by surface plasmon resonance-based competition assayMore data for this Ligand-Target Pair
Affinity DataIC50: 9.70E+3nMAssay Description:Inhibition of human recombinant ACE2More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ABL2 (unknown origin) by Nano-syn mobility shift assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human recombinant Cathepsin L assessed as Kinact using Z-FR-AMC as substrate incubated for 30 mins by fluorometric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.06E+4nMAssay Description:Inhibition of SARS-COV2 spike protein mediated infection of human ACE2 expressing cells at 50 uM by SPR analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 2.63E+4nMAssay Description:Displacement of CPSF6 peptide from HIV1 capsid protein by surface plasmon resonance-based competition assayMore data for this Ligand-Target Pair
TargetDNA repair protein RAD51 homolog 1(Homo sapiens (Human))
Drexel University College Of Medicine
Curated by ChEMBL
Drexel University College Of Medicine
Curated by ChEMBL
Affinity DataIC50: 3.50E+4nMAssay Description:Inhibition of human RAD51-mediated DNA strand exchange at using pBSK (+) gapped and linear dsDNA substrates by joint molecule formation assayMore data for this Ligand-Target Pair
TargetDNA repair protein RAD51 homolog 1(Homo sapiens (Human))
Drexel University College Of Medicine
Curated by ChEMBL
Drexel University College Of Medicine
Curated by ChEMBL
Affinity DataIC50: 3.50E+4nMAssay Description:Inhibition of human RAD51-mediated DNA branch migration using [32P]-labeled 5'-joint molecules after 8 hrs by branch migration assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human wild type full length ACE2 peptide assessed as inhibitionMore data for this Ligand-Target Pair
Affinity DataIC50: 5.70E+4nMAssay Description:Inhibition of human recombinant ACE2 at 50 uM using (7Mca-Y-V-A- D -A-P- K(Knp) as a flurogenic substrate measured after 10 mins by fluorescence base...More data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+4nMAssay Description:Inhibition of HIV1 capsidMore data for this Ligand-Target Pair
Affinity DataIC50: 7.50E+4nMAssay Description:Inhibition of human recombinant Cathepsin L assessed as Kinact using Z-FR-AMC as substrate incubated for 30 mins by fluorometric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8.34E+4nMAssay Description:Inhibition of SARS-COV2 spike protein mediated infection of human ACE2 expressing cells at 50 uM by SPR analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of human recombinant ACE2More data for this Ligand-Target Pair
Affinity DataKd: 2.82E+4nMAssay Description:Binding affinity to HIV1 NL4-3 N-terminal domain capsid protein by surface plasmon resonanceMore data for this Ligand-Target Pair
Affinity DataKd: 3.60E+3nMAssay Description:Binding affinity to HIV1 NL4-3 N-terminal domain capsid protein by surface plasmon resonanceMore data for this Ligand-Target Pair
Affinity DataKd: 1.27E+4nMAssay Description:Binding affinity to HIV1 NL4-3 monomeric capsid protein by surface plasmon resonanceMore data for this Ligand-Target Pair
Affinity DataKd: 2.70E+3nMAssay Description:Binding affinity to HIV1 NL4-3 monomeric capsid protein by surface plasmon resonanceMore data for this Ligand-Target Pair
Affinity DataKd: 64nMAssay Description:Binding affinity to HIV1 NL4-3 hexameric capsid protein by surface plasmon resonanceMore data for this Ligand-Target Pair
Affinity DataKd: 2.41E+4nMAssay Description:Binding affinity to HIV1 NL4-3 hexameric capsid protein by surface plasmon resonanceMore data for this Ligand-Target Pair
Affinity DataKd: 1.40E+4nMAssay Description:Binding affinity to HIV1 NL4-3 monomeric capsid protein by surface plasmon resonanceMore data for this Ligand-Target Pair
